Equity Analysis

Quarterly Results

    Kopran Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    524280
    INE082A01010
    85.8777647
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    KOPRAN
    27.85
    966.19
    EPS(TTM)
    Face Value()
    Div & Yield %:
    7.19
    10
    1.5
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales73.5349.6190.62
Other Operating Income0.000.000.00
Other Income 1.122.128.15
Total Income74.6551.7398.77
Total Expenditure 63.8444.3375.28
PBIDT10.817.4023.49
Interest 0.830.691.78
PBDT9.986.7121.71
Depreciation1.231.201.16
Tax2.131.405.23
Fringe Benefit Tax0.000.000.00
Deferred Tax0.02-0.130.01
Reported Profit After Tax6.604.2515.31
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item6.604.2515.31
EPS (Unit Curr.)1.370.883.18
EPS (Adj) (Unit Curr.)1.370.883.18
Calculated EPS (Unit Curr.)1.370.883.18
Calculated EPS (Adj) (Unit Curr.)1.370.883.18
Calculated EPS (Ann.) (Unit Curr.)5.483.5212.70
Calculated EPS (Adj) (Ann.) (Unit Curr.)5.483.5212.70
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity48.2148.2148.21
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)14.7014.9225.92
PBDTM(%)13.5713.5323.96
PATM(%)8.988.5716.89
Dividend Per Share(Rs)0.000.000.00
Diluted EPS1.370.873.17